Published in Nutrients on June 03, 2011
Fusobacterium is associated with colorectal adenomas. PLoS One (2013) 1.99
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol (2012) 1.98
Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice. Gastroenterology (2013) 1.86
Gut microbiomes of Indian children of varying nutritional status. PLoS One (2014) 1.25
A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol (2013) 1.25
A pig model of the human gastrointestinal tract. Gut Microbes (2013) 1.15
Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer. Mol Cancer (2014) 1.00
Multi-therapeutic effects of human adipose-derived mesenchymal stem cells on radiation-induced intestinal injury. Cell Death Dis (2013) 0.99
Gut microbiota imbalance and colorectal cancer. World J Gastroenterol (2016) 0.99
Campylobacter jejuni induces extra-intestinal immune responses via Toll-like-receptor-4 signaling in conventional IL-10 deficient mice with chronic colitis. Eur J Microbiol Immunol (Bp) (2012) 0.96
Recommendations for probiotic use in humans-a 2014 update. Pharmaceuticals (Basel) (2014) 0.92
Regulation of lung immunity and host defense by the intestinal microbiota. Front Microbiol (2015) 0.92
Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review. Eur J Nutr (2015) 0.91
Probiotics and Nonalcoholic Fatty liver Disease. Middle East J Dig Dis (2013) 0.88
Suppression of Inflammatory Arthritis by Human Gut-Derived Prevotella histicola in Humanized Mice. Arthritis Rheumatol (2016) 0.87
Long-lasting effects of early-life antibiotic treatment and routine animal handling on gut microbiota composition and immune system in pigs. PLoS One (2015) 0.85
The effect of dietary resistant starch type 2 on the microbiota and markers of gut inflammation in rural Malawi children. Microbiome (2015) 0.85
Impact of kefir derived Lactobacillus kefiri on the mucosal immune response and gut microbiota. J Immunol Res (2015) 0.85
Rescue of Fructose-Induced Metabolic Syndrome by Antibiotics or Faecal Transplantation in a Rat Model of Obesity. PLoS One (2015) 0.85
Bugging inflammation: role of the gut microbiota. Clin Transl Immunology (2016) 0.84
Use of 16S rRNA Gene-Targeted Group-Specific Primers for Real-Time PCR Analysis of Predominant Bacteria in Mouse Feces. Appl Environ Microbiol (2015) 0.84
Gut microbiota: its role in hepatic encephalopathy. J Clin Exp Hepatol (2014) 0.83
Perspective: a systems approach to diabetes research. Front Genet (2013) 0.82
Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation. FEMS Microbiol Ecol (2013) 0.81
Microbial activation of gut dendritic cells and the control of mucosal immunity. J Interferon Cytokine Res (2013) 0.80
Splanchnic-aortic inflammatory axis in experimental portal hypertension. World J Gastroenterol (2013) 0.80
The canine isolate Lactobacillus acidophilus LAB20 adheres to intestinal epithelium and attenuates LPS-induced IL-8 secretion of enterocytes in vitro. BMC Microbiol (2015) 0.80
Injection of Lactobacillus casei strain Shirota affects autonomic nerve activities in a tissue-specific manner, and regulates glucose and lipid metabolism in rats. J Diabetes Investig (2013) 0.80
Regional variation in expression of pro-inflammatory mediators in the intestine following a combined insult of alcohol and burn injury. Alcohol (2015) 0.79
Gut-central nervous system axis is a target for nutritional therapies. Nutr J (2012) 0.79
Nutrition of the critically ill — a 21st-century perspective. Nutrients (2013) 0.78
Gut microbiota, inflammation and hepatic encephalopathy: a puzzle with a solution in sight. J Clin Exp Hepatol (2012) 0.77
Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum. BMC Res Notes (2015) 0.76
Influence of different probiotic lactic Acid bacteria on microbiota and metabolism of rats with dysbiosis. Biosci Microbiota Food Health (2013) 0.76
Bacteroides fragilis Lipopolysaccharide and Inflammatory Signaling in Alzheimer's Disease. Front Microbiol (2016) 0.75
Enterococcus faecium HDRsEf1 Protects the Intestinal Epithelium and Attenuates ETEC-Induced IL-8 Secretion in Enterocytes. Mediators Inflamm (2016) 0.75
Enterococcus durans EP1 a Promising Anti-inflammatory Probiotic Able to Stimulate sIgA and to Increase Faecalibacterium prausnitzii Abundance. Front Immunol (2017) 0.75
Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota. FEMS Microbiol Ecol (2016) 0.75
Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus. Sci Rep (2017) 0.75
Comparative In silico Analysis of Butyrate Production Pathways in Gut Commensals and Pathogens. Front Microbiol (2016) 0.75
Gut-liver axis: role of inflammasomes. J Clin Exp Hepatol (2013) 0.75
The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α. Nutrients (2017) 0.75
Preserved Gut Microbial Diversity Accompanies Upregulation of TGR5 and Hepatobiliary Transporters in Bile Acid-Treated Animals Receiving Parenteral Nutrition. JPEN J Parenter Enteral Nutr (2016) 0.75
Gut bacteria and melamine toxicity. Environ Health Perspect (2013) 0.75
Probiotic supplementation in preterm infants does not affect the risk of retinopathy of prematurity: a meta-analysis of randomized controlled trials. Sci Rep (2017) 0.75
Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry. PLoS One (2017) 0.75
The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development. Clin Exp Nephrol (2016) 0.75
A core gut microbiome in obese and lean twins. Nature (2008) 52.30
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15
Microbial ecology: human gut microbes associated with obesity. Nature (2006) 36.98
Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53
The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A (2004) 26.56
Bacterial community variation in human body habitats across space and time. Science (2009) 24.84
Inflammatory bowel disease. N Engl J Med (2002) 21.17
Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol (2001) 18.80
Liver fibrosis. J Clin Invest (2005) 17.27
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
CD4+CD25high regulatory cells in human peripheral blood. J Immunol (2001) 11.25
The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int J Syst Bacteriol (1994) 11.11
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol (2001) 11.07
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 10.74
Concern Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 10.70
Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science (2006) 9.95
Elevated C-reactive protein levels in overweight and obese adults. JAMA (1999) 9.94
TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med (2007) 9.77
Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products. Chem Biol (1998) 9.46
The many faces of macrophage activation. J Leukoc Biol (2003) 8.95
Mucosal flora in inflammatory bowel disease. Gastroenterology (2002) 8.42
Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation (2003) 8.29
Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A (2009) 8.25
Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem (1999) 7.81
Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A (2006) 7.77
Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4) J Exp Med (1999) 7.62
Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science (2003) 7.49
Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol (1983) 7.47
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet (2001) 6.82
Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol (2002) 6.74
The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol (2008) 6.56
Towards the human intestinal microbiota phylogenetic core. Environ Microbiol (2009) 5.72
Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun (2000) 5.65
Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol (2005) 5.62
Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol Ecol (2002) 5.44
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut (2004) 5.32
Global diversity in the human salivary microbiome. Genome Res (2009) 5.16
Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol (2002) 5.08
Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect (1985) 4.73
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology (2004) 4.45
Metagenomic study of the oral microbiota by Illumina high-throughput sequencing. J Microbiol Methods (2009) 4.32
Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun (1979) 4.10
Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology (2004) 4.06
The liver as an immunological organ. Hepatology (2006) 3.86
Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol (2009) 3.80
Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One (2010) 3.64
Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol (2004) 3.63
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep (2001) 3.55
NOD-like receptors: role in innate immunity and inflammatory disease. Annu Rev Pathol (2009) 3.39
Environmental shotgun sequencing: its potential and challenges for studying the hidden world of microbes. PLoS Biol (2007) 3.26
Microbial synergy in experimental intra-abdominal abscess. Infect Immun (1976) 3.21
The biology of intestinal immunoglobulin A responses. Immunity (2008) 3.18
The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol (1979) 3.09
Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol (2002) 3.00
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol (2005) 2.90
Macrophages in inflammation. Curr Drug Targets Inflamm Allergy (2005) 2.85
Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut (2006) 2.85
Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology (2005) 2.78
Alcohol and hepatocellular carcinoma. Gastroenterology (2004) 2.61
Endotoxin and bacteria in portal blood. Gastroenterology (1977) 2.44
Molecular biological evidence for the occurrence of uncultured members of the actinomycete line of descent in different environments and geographical locations. Microbiology (1996) 2.44
High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut (2006) 2.43
The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol (2001) 2.42
TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem (2002) 2.37
Cytokines in alcoholic liver disease. Semin Liver Dis (1999) 2.37
The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol (2009) 2.35
Toll-like receptors as targets in chronic liver diseases. Gut (2009) 2.29
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28
Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology (1994) 2.22
Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol Ecol (2005) 2.18
Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial. Am J Transplant (2005) 2.08
Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol (2004) 2.04
Alcoholic liver disease and the gut-liver axis. World J Gastroenterol (2010) 2.02
Probiotics in the management of atopic eczema. Clin Exp Allergy (2000) 2.00
Ultrastructure of Butyrivibrio fibrisolvens: a gram-positive bacterium. J Bacteriol (1977) 1.96
Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology (2006) 1.96
Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol (2005) 1.93
A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukoc Biol (2002) 1.91
Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J Immunol (2002) 1.88
PROBIOTICS: GROWTH-PROMOTING FACTORS PRODUCED BY MICROORGANISMS. Science (1965) 1.88
The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg (1990) 1.87
Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection. Inflamm Bowel Dis (2007) 1.85
Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am J Pathol (2002) 1.80
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther (2006) 1.76
Isolation and identification of encapsulated strains of Bacteroides fragilis. J Infect Dis (1977) 1.74
Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol (2007) 1.69
Antigen processing and presentation by intestinal epithelial cells - polarity and complexity. Immunol Today (2000) 1.65
The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut (2000) 1.65
Ultrastructural characteristics of distal duodenum mucosa in patients with cirrhosis. Eur J Gastroenterol Hepatol (2002) 1.65
Endotoxin, reticuloendothelial function, and liver injury. Hepatology (1982) 1.64
Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr (2000) 1.63
Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol (2008) 1.63
Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. J Med Microbiol (2005) 1.61
Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol (2010) 1.60
Pulse probiotic administration induces repeated small intestinal Muc3 expression in rats. Pediatr Res (2011) 0.84